Trial intelligence / Profile preview

Dietary Acid Reduction and Progression of Chronic Kidney Disease

NCT06046924Completed

Start
Jun 1996
Primary completion
Nov 2006
Modality
Small Molecules
01

Overview

Randomised, open-label trial of sodium bicarbonate in chronic kidney disease (CKD) and hypertension (HTN) (3 arms). Primary endpoints: Estimated Glomerular Filtration Rate at 5 years, Rate of Estimated Glomerular Filtration Rate Change at 5 years and 4 more. Started Jun 1996; status: completed.

02

Drugs

sodium bicarbonate
03

Conditions

chronic kidney disease (CKD)hypertension (HTN)

Beyond the preview

Go deeper on NCT06046924.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06046924.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call